LEADER 02065nam  2200445z- 450 
001 9910557254803321
005 20231214133030.0
035   $a(CKB)5400000000041409
035   $a(oapen)https://directory.doabooks.org/handle/20.500.12854/73763
035   $a(EXLCZ)995400000000041409
100   $a20202111d2020      |y             0
101 0 $aeng
135   $aurmn|---annan
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aAdvanced Theranostic Nanomedicine in Oncology
210   $cFrontiers Media SA$d2020
215   $a1 electronic resource (187 p.)
311   $a2-88963-621-6 
330   $aDespite the vast and increasing scientific literature on the treatment of malicious diseases such as cancer, we are still far to accomplish most of the current unmet clinical desiderata. A special interest in the biomedical field has been recently directed towards ?theranostic? devices, aiming at combining diagnostic and therapeutic functionalities into a single platform, and thus enabling both early detection of the pathology and its focused and targeted treatment. This Research Topic deals with the synthesis and the physicochemical characterization of theranostic agents at the nano- and/or micro-scale, as well as with their biological and medical evaluation for potential future applications.
606   $aCivil engineering, surveying & building$2bicssc
606   $aBiotechnology$2bicssc
610   $ananoparticles
610   $ananofibers
610   $aoncology
610   $asmart theranostics
610   $aglioblastoma
615  7$aCivil engineering, surveying & building
615  7$aBiotechnology
700   $aCiofani$b Gianni$4edt$01328495
702   $aMarino$b Attilio$4edt
702   $aTapeinos$b Christos$4edt
702   $aCiofani$b Gianni$4oth
702   $aMarino$b Attilio$4oth
702   $aTapeinos$b Christos$4oth
906   $aBOOK
912   $a9910557254803321
996   $aAdvanced Theranostic Nanomedicine in Oncology$93038612
997   $aUNINA